SLFN11 is often methylated in human stomach cancer, and experimental findings demonstrated that SLFN11 functions as a tumor suppressor in human gastric cancer, and that methylation of SLFN11 may act as a marker for cisplatin resistance in stomach cancer cells. This evidence concerns the gene SLFN11 and gastric cancer.